|
IMNM Immunome Inc 1472012 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-53,839,000.00 |
| Balance Sheet |
|
Current Assets
|
$594,309,000.00 |
|
Assets
|
$619,792,000.00 |
|
Current Liabilities
|
$27,412,000.00 |
|
Liabilities
|
$31,106,000.00 |
|
Equity
|
$588,686,000.00 |
|
Shares Out
|
113171396.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-58,638,000.00 |
|
Investing Cash Flow
|
$-12,016,000.00 |
| Market Analysis |
Market Cap
|
$2,611,995,819.68 |
|
Price
|
$22.48 |
|
BVPS
|
5.20 |
|
PB
|
4.44 |
|
EPS
|
-0.48 |
|
FCF
|
$-61,640,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-2.43 |
|
|
2026-05-12 |
-0.48 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMNM documents filed with the SEC.
IMNM Filings
Clear
